/
/
/

Aspira Pathlab & Diagnostics Results

Financial overview

Peer Comparison

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%

Cash Flow

Consolidated
Standalone
₹
%

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Empty box

No results found

Share Market Cap & Key Ratios Overview

Empty box

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Empty box

No results found

Aspira Pathlab & Diagnostics Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹92.9Lakh; with other income of ₹10.8Lakh, profit before interest and tax came to ₹56.4Lakh. Interest expense was ₹9.4Lakh; PBT before exceptional items stood at ₹47Lakh. Basis: consolidated annual results.

Aspira Pathlab & Diagnostics Ltd Quaterly Results Key Takeaways

Aspira Pathlab & Diagnostics Ltd reported ₹5.25Cr total income from operations in Jun 2025, softer than ₹5.78Cr in Mar 2025 but higher than ₹4.64Cr in Jun 2024. Operating profit (before other income, interest and exceptional items) was ₹92.9Lakh; with other income of ₹10.8Lakh, profit before interest and tax came to ₹56.4Lakh. Interest expense was ₹9.4Lakh, taking profit before tax to ₹47Lakh. After tax of ₹0 cr, profit after tax stood at ₹47Lakh (vs ₹72.3Lakh in Mar 2025 and ₹-₹1.6Lakh in Jun 2024).